1. Abshagen U (1987) A new molecule with vasodilating and β-adrenoceptor blocking properties. J Cardiovasc Pharmacol 10 [Suppl 11]: 23–32
2. Boggett D, Blond J, Rolfe P (1985) Laser Doppler measurement of blood flow in skin tissue. J Biomed Eng 7: 225–232
3. Hattori Y, Nakaya H, Endou M, Nakao Y, Kanno M (1989) Vascular effects of carvedilol, an new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery, J Cardiovasc Pharmacol 13: 572–579
4. Needleman P, Corr P, Johnson E (1985) In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) Goodman and Gilman's The pharmacologic basis of therapeutics, 7th edn. Macmillan, New York, pp 806–826
5. Nichols AJ, Sulpizio AC, Ashton D, Hieble JP, Ruffolo RR Jr (in press) In vitro pharmacological profile of the novel β-adrenoceptor antagonist/vasodilator, carvedilol. Pharmacology